SAN FRANCISCO, April 08, 2016 -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts Fly Leasing Limited (NYSE:FLY) investors of the May 24, 2016 lead plaintiff deadline in the securities class action lawsuit related to the Company’s improper accounting for business combinations, including intangible assets and liabilities for aircraft acquired with in-place leases.
If you suffered significant losses because of your purchases of FLY between May 8, 2014 and March 7, 2016 or have information that will help our investigation contact Hagens Berman Partner Reed Kathrein, who is leading the firm’s investigation by calling 510-725-3000, emailing [email protected] or visiting https://www.hbsslaw.com/cases/FLY. The lawsuit was filed in the U.S. District Court for the Southern District of New York and investors have until May 24, 2016 to move the court to participate as a lead plaintiff.
On March 8, 2016, FLY announced that it and the U.S. Securities and Exchange Commission were “currently discussing FLY’s accounting policy for business combinations, including FLY’s accounting policy for intangible assets and liabilities for aircraft acquired with in-place leases.” The Company stated “the impact could be material to FLY’s previously issued consolidated financial statements and require modification to its accounting for the current and prior year results[.]” As a result of this news, the price of FLY stock fell $1.12, or 8.2%, to close at $12.47 per share on March 8, 2016.
The class action complaint alleges that throughout the Class Period, FLY made materially false and misleading statements and failed to disclose material adverse facts about its business, operational and compliance policies. More specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (a) during fiscal years 2014 and 2015, FLY improperly accounted for intangible assets and liabilities for aircraft acquired with in-place leases; and (b) as a result of this misconduct, FLY’s public statements were materially false and misleading at all relevant times.
Whistleblowers: Persons with non-public information regarding Amaya, Inc. should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
Hagens Berman is headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter, and visit the blog. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Anta Sports Expands Global Footprint With Strategic Puma Stake
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



